Dec 19 () - BioMarin Pharmaceutical said on Friday it would acquire Amicus Therapeutics for about $4.8 billion, expanding ​its presence in rare metabolic diseases.

BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet

Astrophotographer Josh Dury has captured the beauty of the Geminids in this stunning timelapse exposure.

Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025

Even when information is factually accurate, how it’s presented can introduce subtle biases. As large language models increasingly bring people the news, this bias is a looming problem.

People are getting their news from AI – and it’s altering their views

C-reactive protein – a marker of inflammation – is as easily measured with blood work in a doctor’s office as cholesterol.

How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker

NASA's Perseverance Mars rover could break the record for miles driven on another planet

Picking the right tires for old drivers is significant for guaranteeing security, solace, and simplicity of driving. Tires that deal


6 Tire Brands Reasonable for Seniors


With regards to choosing the best spending plan well disposed and solid tire brands for 2024, there are a few phenomenal choices that


6 Modest and Strong Tire Brands


Picking the best tire brands for 2024 is fundamental for guaranteeing wellbeing, execution, and strength out and about. With various


LATEST POSTS